News – Page 532 – Endpoints News

Less than two years after nine-figure IPO, Applied Molecular Transport cuts back on staff, pipeline efforts

4 years ago

Locus pulls in a modest Series B as it attempts to emulate oncology's precision medicine model in antibacterials

4 years ago

With seizure drug held up at FDA again, Aquestive replaces longtime CEO

4 years ago

Chinese pharma giant Hengrui launches new company for globalization play — with a Merck KGaA vet at the helm

4 years ago

Under-the-radar Chinese biotech scores $47M upfront in secretive Merck deal around cancer drug

4 years ago

Senate user fee reauthorization bill omits accelerated approval reforms, shows wide gaps with House version

4 years ago

As new C. diff treatments prep for market, specialists divided on 'poop in a pill' or small molecule, study finds

4 years ago

Berkshire Hathaway pulls out of AbbVie, Bristol Myers Squibb investments

4 years ago

Long-expected UK layoffs imminent for Novartis following sale

4 years ago

FDA authorizes booster dose of Pfizer and BioNTech's Covid-19 vaccine in 5- to 11-year-olds

4 years ago

Greece goes on offensive against Novartis, filing a lawsuit in aftermath of bribery scheme

4 years ago

FDA lobbies Congress over rare disease court ruling with wide implications

4 years ago

Even FDA's Peter Marks is worried about the commercial viability of gene and cell therapies

4 years ago

Pricy inhalers remain expensive due to device tweaks that keep competitors at bay, researchers find

4 years ago

MRx roundup: Hologic enlists Sheryl Crow for screenings; J&J QuickFire teams with feds for public health

4 years ago

Perpetual crisis? Pharma communications and public relations pros just wait for the next shoe to drop

4 years ago

A long time coming: GlaxoSmithKline officially changes name to GSK

4 years ago

An 'interestingly porous' pouch: Two startups team up on a potentially new way to treat diabetes

4 years ago

Regeneron-backed oncolytic virus startup scores modest Series B extension

4 years ago

Genomics biotech undergoes a facelift, rebranding from Clover to Character Biosciences

4 years ago

Cytokinetics' long and winding road to develop its lead heart drug will face an adcomm this fall

4 years ago

London biotech completes $2.5M micro IPO; AGTC touts early gene therapy data — but investors keep their distance

4 years ago

Presenting a live Endpoints News event: Managing a biotech in turbulent times

4 years ago

Amidst R&D reshuffle, Vertex expands its presence in Boston, aiming to become number one

4 years ago

First page Previous page 529 530 531532533 534 535 Next page Last page